Drug Shortage Report for BENLYSTA
| Report ID | 213253 |
| Drug Identification Number | 02370050 |
| Brand name | BENLYSTA |
| Common or Proper name | Belimumab for injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BELIMUMAB |
| Strength(s) | 120MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1x5ML |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-13 |
| Estimated end date | 2024-02-09 |
| Actual end date | 2024-02-06 |
| Shortage status | Resolved |
| Updated date | 2024-02-07 |
| Company comments | For emergency supply, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2024-02-07 | French | Compare |
| v10 | 2024-02-07 | English | Compare |
| v9 | 2024-01-22 | French | Compare |
| v8 | 2024-01-22 | English | Compare |
| v7 | 2024-01-02 | French | Compare |
| v6 | 2024-01-02 | English | Compare |
| v5 | 2023-12-21 | French | Compare |
| v4 | 2023-12-21 | English | Compare |
| v3 | 2023-12-14 | English | Compare |
| v2 | 2023-12-13 | French | Compare |
| v1 | 2023-12-13 | English | Compare |
Showing 1 to 11 of 11